Form 4 for BCYC BICYCLE THERAPEUTICS PLC
Accepted 2021-09-03 00:00:00 ET · period of report 2021-09-01 · accession 0001209191-21-054787 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-03 | 2021-09-01+ | BCYC | Lee Kevin | CEO, Dir | S - Sale+OE | $37.65 | -32.1K | 235.1K | -12% | -$1.21M |
| D | 2021-09-03 | 2021-09-01 | BCYC | Lee Kevin | CEO, Dir | M - OptEx | $14.00 | +22.9K | 267.2K | +9% | +$320.5K |
| D | 2021-09-03 | 2021-09-01 | BCYC | Lee Kevin | CEO, Dir | M - OptEx | $0.00 | -22.9K | 306.3K | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2021-09-01 | S | D | 1,796 | $38.08 | 240,085 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.00 to $38.255 inclusive. |
| 2 | Common | Ordinary Shares | 2021-09-01 | S | D | 17,098 | $37.52 | 241,881 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.99 inclusive. |
| 3 | Common | Ordinary Shares | 2021-09-01 | S | D | 8,191 | $36.38 | 258,979 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.975 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4). |
| 4 | Common | Ordinary Shares | 2021-09-02 | S | D | 5,000 | $40.00 | 235,085 | D | — | — | |
| 5 | Common | Ordinary Shares | 2021-09-01 | M | A | 22,890 | $14.00 | 267,170 | D | — | — | |
| 6 | Derivative | Stock Option (right to buy) | 2021-09-01 | M | D | 22,890 | $0.00 | 306,252 | D | $14.00 · — to 2029-06-28 | 22,890 Ordinary Shares | (F5) This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant. |